Main Article Content

Abstract

Ulcerative colitis is one of the most significant problems of modern gastroenterology. The constant increase in morbidity, disability of the population, as well as the high prevalence of the overwhelming number of cases among the working-age population aged 20-40 years, makes this pathology socially significant [7; 8; 9].

Keywords

lymphatic therapy abdominal surgery

Article Details

How to Cite
Ruziev Axtam Ergashovich. (2020). JUSTIFICATION OF THE USE OF THE METHOD OF LYMPHATIC THERAPY TO IMPROVE THE RESULTS IN THE COMPLEX TREATMENT OF ULCERATIVE COLITIS. International Journal of Human Computing Studies, 2(6), 28-30. https://doi.org/10.31149/ijhcs.v2i6.1021

References

  1. 1. Andreev P. S. endolymphatic antibacterial and immunostimulating therapy in the complex treatment of patients with exacerbation of non-specific ulcerative colitis: dissertation ... candidate of medical sciences: 14.01.17. - samara, 2013. - 169 p.: il.
  2. 2. Asaninyu. Yu. et al. Maseevich index: A new approach to assessing the clinical and endoscopic activity of ulcerative colitis / / Gastroenterology. St. Petersburg. 2004. No. 1. pp. 14-16.
  3. 3. Vorob'ev G. I. Surgical treatment of complications of non-specific ulcerative colitis / G. I. Vorob'ev, N. V. Kostenko, T. L. Mikhailova, L. L. Kapuller, V. V. Veselov / / Russian Journal of Gastroenterology, hepatology, coloproctology. - 2003. - Vol. 13, No. 1. - pp. 73-80.
  4. 4. Vyrenkov Yu. E., Vtorenko V. I. Lymphological methods in the complex treatment of surgical pathology // Anal surgery. 1996. No. 1. S. 50-54.
  5. 5. Ivashkin v. t. rational pharmacotherapy of diseases of the digestive system: hands. dlyaprakt.physicians // Ivashkin V. T., Lapina T. L.; under the General editorship of ivashkina v. t.-m: litterra, 2007. from 1056.
  6. 6. Kanshina O. A. Nonspecific ulcerative colitis in children (and adults) / O. A. Kanshina, N. N. Kanshin. - M.: Bioinformservis, 2002. - 212 p.
  7. 7. Osikov M. V., simonyan e. v., bakeeva a. e., kostina a. a. experimental modeling of crohn's disease and ulcerative colitis // modern problems of science and education. – 2016. – № 4.;
  8. 8. Sovalkin V. I. Biological therapy of inflammatory bowel diseases // Experimental and clinical gastroenterology. – 2010. – No. 3. - pp. 83-84.
  9. 9. Egamov Yu. S., Ruziev A. E. The significance of endomesenteric lymphatic therapy in the complex treatment of non-specific ulcerative colitis in the postoperative period. / / journalproblems of Biology and Medicine. -2019, -№3 (111). –P. 163-167.
  10. 10. Zimmerman Ya. S. Classification of major gastroenterological diseases and syndromes. - 3rd ed. - Perm: PGMA, 2012.
  11. 11. Aratari A., Papich., Clemente V., Moretti A., Luchetti R., Koch M., Capurso L., Caprillir.The frequency of colectomy in acute severe ulcerative colitis in the era of infliximab / / Dis. ... kand. med. nauk, 2008. Volume 40. pp. 821-826.
  12. 12. Gassull M., Estev M. steroid immunity in inflammatory bowel diseases / / Advanced therapy of inflammatory bowel diseases (ed. Bayless T. M., Hanauer S. B.). - London: B. K. Decker, 2001. - pp. 133-137.
  13. 13. Petersson, J. the importance and regulation of the colon mucosal barrier in the mouse model of colitis / J. Petersson, O. Schreiber, L. Holm, M. Phillipson, G. K. Hansson, S. J. Gendler, A. Velcic, J. O. Lundberg, S. Roos // American Journal of Physiology - physiology of the gastrointestinal tract and liver. - № 300 (2011), 2,- P. G327-G333.
  14. 14. Sankaran-Walters S., makal M., Grishina I., Nagy L. et al. Sex differences matter in the gut: implications for immune activation and inflammation of the mucous membrane / / Biol. sexdiffer. - 2013. - №4 (10).-Pp. 1-12.